Ariadne Wealth Management »

Alnylam Pharmaceuticals shares owned by Ariadne Wealth Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Ariadne Wealth Management from 13F filings

Historical chart of Ariadne Wealth Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Ariadne Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Ariadne Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $319k 703 453.97
2025-06-30 $219k 506 432.52
2024-12-31 $286k 1.0k 274.06
2024-09-30 $233k 855 272.22

More positions owned by Ariadne Wealth Management

Ishares Silver Tr Ishares (SLV)
Dimensional Etf Trust Us Mktwide Value (DFUV)
American Centy Etf Tr Us Eqt Etf (AVUS)
Blackrock Etf Trust Ii Ishares Short-te (CALI)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Spdr Gold Tr Gold Shs (GLD)
Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Ultra Short Dur (ICSH)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Internatnal Val (DFIV)
Broadcom (AVGO)

View all positions for Ariadne Wealth Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals